CRIS Current Research Information System

FRANCHINI, EUGENIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.739
NA - Nord America 2.324
EU - Europa 1.828
AF - Africa 196
SA - Sud America 111
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.211
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.276
VN - Vietnam 1.032
SG - Singapore 622
CN - Cina 581
GB - Regno Unito 428
IT - Italia 341
SE - Svezia 245
DE - Germania 215
HK - Hong Kong 139
FR - Francia 121
NL - Olanda 94
IN - India 93
RU - Federazione Russa 79
BR - Brasile 78
IE - Irlanda 62
KR - Corea 56
JP - Giappone 55
TG - Togo 53
FI - Finlandia 51
NG - Nigeria 41
ZA - Sudafrica 39
CA - Canada 36
CI - Costa d'Avorio 35
EE - Estonia 29
BG - Bulgaria 28
JO - Giordania 25
UA - Ucraina 25
BE - Belgio 24
PH - Filippine 17
SC - Seychelles 17
TH - Thailandia 17
AT - Austria 16
ID - Indonesia 16
CH - Svizzera 15
BD - Bangladesh 14
AR - Argentina 13
PL - Polonia 13
IQ - Iraq 10
ES - Italia 8
MX - Messico 8
TR - Turchia 8
UZ - Uzbekistan 8
AU - Australia 7
GR - Grecia 7
TW - Taiwan 7
IR - Iran 6
PY - Paraguay 6
KE - Kenya 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
EU - Europa 4
HR - Croazia 4
LT - Lituania 4
MK - Macedonia 3
MY - Malesia 3
NP - Nepal 3
PE - Perù 3
RO - Romania 3
CO - Colombia 2
DK - Danimarca 2
EC - Ecuador 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LV - Lettonia 2
MA - Marocco 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SA - Arabia Saudita 2
SN - Senegal 2
VE - Venezuela 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CY - Cipro 1
EG - Egitto 1
GE - Georgia 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
MD - Moldavia 1
MT - Malta 1
MV - Maldive 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 7.211
Salva come PNG Salva come JPEG
Città #
Singapore 436
Dong Ket 425
Southend 381
Ashburn 298
Chandler 219
Fairfield 150
Ho Chi Minh City 150
Ann Arbor 134
San Jose 131
Hanoi 128
Hong Kong 127
Beijing 94
Hefei 87
Seattle 87
Bologna 81
Houston 81
Wilmington 74
Woodbridge 70
Cambridge 67
Boardman 64
Dublin 62
Princeton 58
Lomé 53
New York 50
Tokyo 48
Milan 45
Santa Clara 44
Seoul 40
Los Angeles 37
Abidjan 35
Helsinki 33
Lauterbourg 33
Munich 32
Abeokuta 29
Westminster 29
Nanjing 28
Padova 28
Sofia 28
Medford 25
Amman 24
Brussels 23
Frankfurt am Main 22
Haiphong 21
Bremen 18
Redondo Beach 18
Jinan 17
Berlin 16
Dallas 15
Hải Dương 15
Buffalo 14
Da Nang 14
Redwood City 14
Toronto 14
Guangzhou 13
Vienna 13
Changsha 12
Hebei 12
Orem 12
Paris 12
Saint Petersburg 12
Shanghai 12
Shenyang 12
Turku 12
Bern 11
Nanchang 11
Jakarta 10
Rome 10
São Paulo 10
Council Bluffs 9
Amsterdam 8
Bengaluru 8
Hyderabad 8
Jiaxing 8
Johannesburg 8
Turin 8
Warsaw 8
Florence 7
Hangzhou 7
Montreal 7
Monzuno 7
Moscow 7
Nuremberg 7
Redmond 7
Can Tho 6
Chengdu 6
Denver 6
Falls Church 6
Lappeenranta 6
London 6
Manchester 6
Romainville 6
San Diego 6
Shijiazhuang 6
Thái Nguyên 6
Zhengzhou 6
Atlanta 5
Bangkok 5
Biên Hòa 5
Brooklyn 5
Bến Tre 5
Totale 4.651
Salva come PNG Salva come JPEG
Nome #
Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery 385
Chromothripsis in acute myeloid leukemia: Biological features and impact on survival 296
Aggressive Aneuploid Acute Myeloid Leukemia Is Dependent on Alterations of P53, Gain of APC and PLK1 and Loss of RAD50 281
Alterations in phosphatidylinositol 3-phosphate (PI3P) pathway and cAMP pathway confirm poor prognosis and reduced overall survival (OS) in a series of 209 acute myeloid leukemia patients 258
The alteration in key regulator genes of autophagy is mainstream mechanism of therapy resistance and impact prognosis of acute myelogenous leukemia (AML): results from diagnosis genomic analysis on 148 consecutive patients treated with intensive chemotherapy and long-term survival follow-up 255
Co-occurrence of alterations in the DNA damage repair genes synergize with uncontrolled proliferation and associate with very-poor prognosis in acute myeloid leukemia patients 252
Alterations of BRCA1 and PALB2 Define a Novel Class of Complex-Karyotype AML with a Very Bad Prognosis 249
Alterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 248
Chromothripsis in Acute Myeloid Leukemia Is Strongly Associated with Poor Prognosis and TP53 Alterations 231
A cell cycle-related genomic and transcriptomic signature distinguish aneuploid and euploid acute myeloid leukemia 229
H&E and OCT4/CD34 for the assessment of lympho-vascular invasion in seminoma and embryonal carcinoma 217
Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients 208
Copy number variants signature in two patients with relapsed acute promyelocytic leukemia 204
Deficient necroptosis pathway as a negative prognostic factor in acute myeloid leukemia. 200
Novel Genomic Patterns of Metabolic Remodeling in Acute Myeloid Leukemia 198
Microarray analysis to identifiy novel copy number alterations in acute myeloid leukemia 192
Survival analysis of patients carrying different FLT3 mutations (internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations) in 459 consecutive non M3 newly diagnosed acute myeloid leukemia (AML) 188
The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric study 185
Gemtuzumab-Ozogamicin Containing Regimens As Induction Therapy Give the Highest Complete Remission Rate and the Longest Overall Survival Compared with Other Induction Regimens in Patients with Newly Diagnosed Acute Myeloid Leukemia 182
Very Poor Outcome and Chemoresistance of Acute Myeloid Leukemia Patients with TP53 Mutations: Correlation with Complex Karyotype and Clinical Outcome 178
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome 174
Survival and outcome data observed in 98 patients affected by acute myeloid leukemia undergoing chemotherapy consolidation courses treatment followed by autologous bone marrow transplantation (auto-BMT) 173
Two or More Chemotherapy Consolidation Courses, Followed By Autologous Bone Marrow Transplantation, and MRD Negativity, Give Long Term Overall Survival in Acute Myeloid Leukemia Patients 173
Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients 171
"Paradoxical" p16 overexpression in cutaneous melanoma: Molecular and immunohistochemical analysis of a rare phenomenon with a focus on cell cycle regulatory molecules 161
Survival analysis of 409 consecutive patients with newly diagnosed acute myeloid leukemia treated with intensive induction therapy, with or without the addition of gemtuzomab-ozagomicin (GO) 158
Very poor outcome and chemoresistance of acute myeloid leukemia patients with TP53 mutations: Correlation with complex karyotype and clinical outcome 158
TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis 157
You have accessAlterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 157
Evaluation of the Diasorin Q-Lamp technology for the molecular diagnosis of the philadelphia positive leukemias: an italian multicenter study 156
Specific chromosomic alterations confer therapy resistance in a cohort of 49 patients with newly diagnosed acute myeloid leukemia treated with intensive chemotherapy 152
FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type 147
Ultra-Deep Sequencing Strategy Is a Precious Tool to Find Small Clones Harbouring FLT3 Mutations in AML Patients 144
Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT 143
Characterization of testicular embryonic-type neuroectodermal tumor and embryonic-type neuroectodermal tissue admixed with mature neuro-glial tissue using a broad immunohistochemical panel 118
SOX2 and PRAME in the "reprogramming" of seminoma cells 105
Immunohistochemical expression of EZH2 in germ cell tumors of the testis: New insights into the genesis and epigenetic reprogramming of these fascinating tumors 91
Yolk sac tumor of postpubertal-type does not exhibit immunohistochemical loss of SMARCB1/INI1 and SMARCA4/BRG1…but choriocarcinoma? 72
Immunohistochemical expression of Nectin-4 and potential implications for enfortumab vedotin therapy in germ cell tumors of the testis: a preliminary study 63
New insights into Nectin-4 expression in testicular choriocarcinoma and its potential treatment with Enfortumab Vedotin: analysis of a multi-institutional series and association with clinical-pathological features 38
Totale 7.347
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.913
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.913
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021566 0 0 0 0 0 0 0 0 0 0 39 527
2021/2022660 34 26 38 70 64 35 20 29 31 48 144 121
2022/2023914 108 134 54 121 77 69 32 41 144 29 62 43
2023/2024342 18 38 25 60 19 82 14 26 18 14 8 20
2024/20251.002 26 141 96 77 74 27 107 41 21 110 74 208
2025/20262.463 239 173 188 183 265 112 249 61 702 223 68 0
Totale 7.347